AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Contineum Therapeutics, Inc.

$9.39 -$2.00 (-17.56%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$9.33
Day Range
$8.99$9.58
Year Range
$6.72$17.79
Market Cap
309.48M
AVG Volume
719.14K
Trailing/Forward PE
-5.43/-
PEG ratio
0.32
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (USD) · A
020M40M60M202320242025
CTNM Revenue (USD) by year
PeriodRevenue (USD)
20250
20240
202350M
Net Income (USD) · A
-75M-50M-25M025M202320242025
CTNM Net Income (USD) by year
PeriodNet Income (USD)
2025-59.98M
2024-42.26M
202322.72M
Operating Income (USD) · A
-100M-50M050M100M202320242025
CTNM Operating Income (USD) by year
PeriodOperating Income (USD)
2025-68.06M
202450.89M
202316.08M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: CTNM

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

Contineum Therapeutics, Inc.
CTNM
Stockpicker

Video analysis: CTNM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CTNM

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.